Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Digital Technology for Tuberculosis Medication Adherence: Promise and Peril.

Haberer JE, Subbaraman R.

Ann Am Thorac Soc. 2020 Apr;17(4):421-423. doi: 10.1513/AnnalsATS.202001-027ED. No abstract available.

PMID:
32233860
2.

Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: Comparison of digital adherence data with urine isoniazid testing.

Thomas BE, Kumar JV, Chiranjeevi M, Shah D, Khandewale A, Thiruvengadam K, Haberer JE, Mayer KH, Subbaraman R.

Clin Infect Dis. 2020 Mar 28. pii: ciaa333. doi: 10.1093/cid/ciaa333. [Epub ahead of print]

PMID:
32221550
3.

Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural Uganda.

Benitez AE, Musinguzi N, Bangsberg DR, Bwana MB, Muzoora C, Hunt PW, Martin JN, Haberer JE, Petersen ML.

J Int AIDS Soc. 2020 Mar;23(3):e25467. doi: 10.1002/jia2.25467.

4.

Proactively offered text messages and mailed nicotine replacement therapy for smokers in primary care practices: A pilot randomized trial.

Kruse GR, Park ER, Chang Y, Haberer JE, Abroms LC, Shahid NN, Howard S, Haas JS, Rigotti NA.

Nicotine Tob Res. 2020 Mar 21. pii: ntaa050. doi: 10.1093/ntr/ntaa050. [Epub ahead of print]

PMID:
32198520
5.

Experiences and intentions of Ugandan household tuberculosis contacts receiving test results via text message: an exploratory study.

Ggita JM, Katahoire A, Meyer AJ, Nansubuga E, Nalugwa T, Turimumahoro P, Ochom E, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL.

BMC Public Health. 2020 Mar 12;20(1):310. doi: 10.1186/s12889-020-8427-0.

6.

Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.

Ware NC, Wyatt MA, Pisarski EE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, Bangsberg DR, Haberer JE; META Study Team.

AIDS Behav. 2020 Mar 5. doi: 10.1007/s10461-020-02819-z. [Epub ahead of print]

PMID:
32140877
7.

Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study.

Musiimenta A, Tumuhimbise W, Atukunda EC, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE.

Tuberc Res Treat. 2020 Jan 7;2020:7401045. doi: 10.1155/2020/7401045. eCollection 2020.

8.

Experience with antiretroviral electronic adherence monitoring among young African American men who have sex with men living with HIV: findings to inform a triaged real-time alert intervention.

Dworkin MS, Panchal P, Wiebel W, Garofalo R, Jimenez A, Haberer JE.

AIDS Care. 2020 Jan 15:1-10. doi: 10.1080/09540121.2020.1713975. [Epub ahead of print]

PMID:
31941360
9.

Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.

Wanga V, Baeten JM, Bukusi EA, Mugo NR, Asiimwe S, Ngure K, Mujugira A, Muwonge T, Odoyo JB, Haberer JE, Celum C, Heffron R; Partners Demonstration Project Team.

AIDS Behav. 2020 Jan 10. doi: 10.1007/s10461-019-02773-5. [Epub ahead of print]

PMID:
31925607
10.

Protocol for a prospective evaluation of postpartum engagement in HIV care among women living with HIV in South Africa.

Psaros C, Stanton AM, Bedoya CA, Mosery N, Evans S, Matthews LT, Haberer J, Vangel M, Safren S, Smit JA.

BMJ Open. 2020 Jan 9;10(1):e035465. doi: 10.1136/bmjopen-2019-035465.

11.

Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?

Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, Mofenson LM, Mugo N, Myer L, Mujugira A, Shoptaw S, Stranix-Chibanda L, John-Stewart G; PrEP in Pregnancy Working Group.

J Int AIDS Soc. 2020 Jan;23(1):e25426. doi: 10.1002/jia2.25426. Review.

12.

Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.

Musiimenta A, Tumuhimbise W, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE.

J Clin Tuberc Other Mycobact Dis. 2019 Aug 29;17:100119. doi: 10.1016/j.jctube.2019.100119. eCollection 2019 Dec.

13.

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.

Mugendi AG, Kubo MN, Nyamu DG, Mwaniki LM, Wahome SK, Haberer JE.

Neurol Res Int. 2019 Oct 30;2019:5173289. doi: 10.1155/2019/5173289. eCollection 2019.

14.

Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980-2016.

Mbaye R, Gebeyehu R, Hossmann S, Mbarga N, Bih-Neh E, Eteki L, Thelma OA, Oyerinde A, Kiti G, Mburu Y, Haberer J, Siedner M, Okeke I, Boum Y.

BMJ Glob Health. 2019 Oct 18;4(5):e001855. doi: 10.1136/bmjgh-2019-001855. eCollection 2019.

15.

The meaning of "rapid" antiretroviral therapy initiation for adolescents with HIV in sub-Saharan Africa.

Zanoni BC, Haberer JE.

J Infect Dis. 2019 Nov 4. pii: jiz548. doi: 10.1093/infdis/jiz548. [Epub ahead of print] No abstract available.

PMID:
31682259
16.

Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.

Musinguzi N, Castillo-Mancilla J, Morrow M, Byakwaga H, Mawhinney S, Burdo TH, Boum Y, Muzoora C, Bwana BM, Siedner MJ, Martin JN, Hunt PW, Bangsberg DR, Haberer JE.

J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):386-391. doi: 10.1097/QAI.0000000000002148.

PMID:
31658181
17.

Knowledge of HIV Status Is Associated With a Decrease in the Severity of Depressive Symptoms Among Female Sex Workers in Uganda and Zambia.

Ortblad KF, Musoke DK, Chanda MM, Ngabirano T, Velloza J, Haberer JE, McConnell M, Oldenburg CE, Bärnighausen T.

J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):37-46. doi: 10.1097/QAI.0000000000002224.

18.
19.

PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.

Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC.

J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):265-274. doi: 10.1097/QAI.0000000000002139.

PMID:
31609925
20.

High Rates of Biomarker-Confirmed Alcohol Use Among Pregnant Women Living With HIV in South Africa and Uganda.

Raggio GA, Psaros C, Fatch R, Goodman G, Matthews LT, Magidson JF, Amanyire G, Cross A, Asiimwe S, Hahn JA, Haberer JE.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):443-451. doi: 10.1097/QAI.0000000000002156.

21.

Global implementation of PrEP for HIV prevention: setting expectations for impact.

Pyra MN, Haberer JE, Hasen N, Reed J, Mugo NR, Baeten JM.

J Int AIDS Soc. 2019 Aug;22(8):e25370. doi: 10.1002/jia2.25370.

22.

Objective monitoring of mosquito bednet usage and the ethical challenge of respecting study bystanders' privacy.

Krezanoski P, Haberer J.

Clin Trials. 2019 Oct;16(5):466-468. doi: 10.1177/1740774519865525. Epub 2019 Aug 1.

PMID:
31368779
23.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

24.

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE.

Front Pharmacol. 2019 Jul 12;10:785. doi: 10.3389/fphar.2019.00785. eCollection 2019.

25.

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.

Matthews LT, Jaggernath M, Kriel Y, Smith PM, O'Neil K, Haberer JE, Hendrix C, Baeten JM, Ware NC, Wirth K, Psaros C, Bangsberg DR, Smit JA.

BMJ Open. 2019 Jul 26;9(7):e027227. doi: 10.1136/bmjopen-2018-027227.

26.

Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda.

Ortblad KF, Musoke DK, Ngabirano T, Salomon JA, Haberer JE, McConnell M, Oldenburg CE, Bärnighausen T.

J Int AIDS Soc. 2019 Jul;22(7):e25336. doi: 10.1002/jia2.25336.

27.

Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda.

Siedner MJ, Bwana MB, Asiimwe S, Musinguzi N, Castillo-Mancilla J, Amanyire G, Tracy RP, Bangsberg DR, Orrell C, Haberer JE; META Study Investigators.

AIDS. 2019 Nov 1;33(13):2043-2048. doi: 10.1097/QAD.0000000000002305.

28.

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.

Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K.

Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.

29.

Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study.

Siedner MJ, Bwana MB, Asiimwe S, Amanyire G, Musinguzi N, Castillo-Mancilla J, Tracy RP, Katz IT, Bangsberg DR, Hunt PW, Orrell C, Haberer JE; META study investigators .

J Infect Dis. 2019 Aug 30;220(7):1172-1177. doi: 10.1093/infdis/jiz259.

30.

Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale M, Goti V, Bumpus NN, Marzinke MA, Hendrix CW, Haberer JE; Partners Demonstration Project Team.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00446-19. doi: 10.1128/AAC.00446-19. Print 2019 Aug.

31.

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women.

Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM.

Front Pharmacol. 2019 Apr 17;10:401. doi: 10.3389/fphar.2019.00401. eCollection 2019.

32.

High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception Services.

Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Muyindike W, Bennett K, Kembabazi A, Haberer JE, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Matthews LT.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):497-507. doi: 10.1097/QAI.0000000000002053.

PMID:
30973545
33.

A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings.

Dworkin MS, Panchal P, Wiebel W, Garofalo R, Haberer JE, Jimenez A.

BMC Public Health. 2019 Apr 11;19(1):394. doi: 10.1186/s12889-019-6689-1.

34.

Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocol.

Kruse GR, Park E, Haberer JE, Abroms L, Shahid NN, Howard SE, Chang Y, Haas JS, Rigotti NA.

Contemp Clin Trials. 2019 May;80:48-54. doi: 10.1016/j.cct.2019.03.006. Epub 2019 Mar 25.

PMID:
30923022
35.

Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients.

Kruse G, Park ER, Shahid NN, Abroms L, Haberer JE, Rigotti NA.

JMIR Mhealth Uhealth. 2019 Mar 26;7(3):e11498. doi: 10.2196/11498.

36.

The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam.

DeSilva M, Vu CN, Bonawitz R, Hai LT, Van Lam N, Yen LT, Gifford AL, Haberer J, Linh DT, Sabin L.

Trials. 2019 Feb 28;20(1):150. doi: 10.1186/s13063-019-3239-1.

37.

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa.

Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219831011. doi: 10.1177/2325958219831011.

38.

ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.

Haberer JE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, Siedner MJ, Matthews LT, Tsai AC, Katz IT, Bell K, Kembabazi A, Mugisha S, Kibirige V, Cross A, Kelly N, Hedt-Gauthier B, Bangsberg DR.

J Int AIDS Soc. 2019 Feb;22(2):e25232. doi: 10.1002/jia2.25232.

39.

The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda.

Ortblad KF, Kibuuka Musoke D, Ngabirano T, Nakitende A, Harling G, Haberer JE, McConnell M, Salomon JA, Oldenburg CE, Bärnighausen T.

AIDS Behav. 2019 May;23(5):1225-1239. doi: 10.1007/s10461-019-02393-z.

40.

Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda.

Musiimenta A, Atukunda EC, Tumuhimbise W, Haberer JE.

AIDS Care. 2018 Aug;30(sup5):S89-S96. doi: 10.1080/09540121.2018.1510107. Epub 2019 Jan 9.

41.

The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.

Campbell JI, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE, Eyal N.

AIDS Care. 2019 Jun;31(6):761-766. doi: 10.1080/09540121.2018.1556381. Epub 2018 Dec 9.

PMID:
30606037
42.

Screening for HIV and linkage to care in adolescents: insights from a systematic review of recent interventions in high- versus low- and middle-income settings.

Zanoni BC, Elliott RJ, Neilan AM, Haberer JE.

Adolesc Health Med Ther. 2018 Dec 4;9:211-235. doi: 10.2147/AHMT.S153204. eCollection 2018. Review.

43.

Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa.

Magidson JF, Fatch R, Orrell C, Amanyire G, Haberer JE, Hahn JA; META team.

AIDS Behav. 2019 Jun;23(6):1656-1667. doi: 10.1007/s10461-018-2364-2.

44.

Barriers to Retention in Care are Overcome by Adolescent-Friendly Services for Adolescents Living with HIV in South Africa: A Qualitative Analysis.

Zanoni BC, Sibaya T, Cairns C, Haberer JE.

AIDS Behav. 2019 Apr;23(4):957-965. doi: 10.1007/s10461-018-2352-6.

45.

Text Messages Sent to Household Tuberculosis Contacts in Kampala, Uganda: Process Evaluation.

Meyer AJ, Babirye D, Armstrong-Hough M, Mark D, Ayakaka I, Katamba A, Haberer JE, Davis JL.

JMIR Mhealth Uhealth. 2018 Nov 20;6(11):e10239. doi: 10.2196/10239.

46.

Feasibility, Acceptability, and Adoption of Digital Fingerprinting During Contact Investigation for Tuberculosis in Kampala, Uganda: A Parallel-Convergent Mixed-Methods Analysis.

White EB, Meyer AJ, Ggita JM, Babirye D, Mark D, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL.

J Med Internet Res. 2018 Nov 15;20(11):e11541. doi: 10.2196/11541.

47.

Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.

Dunbar MS, Kripke K, Haberer J, Castor D, Dalal S, Mukoma W, Mullick S, Patel P, Reed J, Subedar H, Were D, Warren M, Torjesen K.

Sex Health. 2018 Nov;15(6):513-521. doi: 10.1071/SH18061. Review.

48.

Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.

Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE; Partners Mobile Adherence to PrEP (PMAP) Team.

AIDS Behav. 2019 May;23(5):1267-1276. doi: 10.1007/s10461-018-2326-8.

PMID:
30406335
49.

Feasibility and Acceptability of Real-Time Antiretroviral Adherence Monitoring among Depressed Women Living with HIV in the Deep South of the US.

Stringer KL, Azuero A, Ott C, Psaros C, Jagielski CH, Safren SA, Haberer JE, Kempf MC.

AIDS Behav. 2019 May;23(5):1306-1314. doi: 10.1007/s10461-018-2322-z.

PMID:
30377982
50.

Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.

Subbaraman R, de Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE, Haberer J.

BMJ Glob Health. 2018 Oct 11;3(5):e001018. doi: 10.1136/bmjgh-2018-001018. eCollection 2018.

Supplemental Content

Loading ...
Support Center